Study design: Before-After trial measured prior to cold air therapy, immediately following, after 30 and 60 min. Objective: To determine the effect of cold air therapy in relieving spasticity, the ...
The treatment was already approved for pediatric upper limb spasticity earlier this year. This new approval was based on data from a phase 3 trial evaluating the safety and efficacy of Botox in 381 ...
Allergan announced that the Food and Drug Administration (FDA) has approved Botox (onabotulinumtoxinA) for the treatment of lower limb spasticity in adults to decrease the severity of increased muscle ...
Background OnabotulinumtoxinA has demonstrated significant benefit in adult focal spasticity. This study reviews the injection patterns (i.e., muscle distribution, dosing) of onabotulinumtoxinA for ...
In the United States, someone has a stroke every 40 seconds.[i] Though stroke death rates have declined in recent decades, it is a leading cause of serious long-term disability,[ii] taking a toll on ...
BURLINGTON, Ontario, December 17, 2024--(BUSINESS WIRE)--Merz Therapeutics, a business of Merz Group and a leader in the field of neurotoxins, today announced that Health Canada approved XEOMIN ® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback